Informação sobre produto
- 1H-Indole-1-carboxamide, 2,3-dihydro-3,3-dimethyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-, endo-
- 2,3-Dihydro-3,3-dimethyl-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-1H-indole-1-carboxamide
- BRL 46470
- 1H-Indole-1-carboxamide, 2,3-dihydro-3,3-dimethyl-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-
Ricasetron is a type of serotonin receptor antagonist that is used to prevent nausea and vomiting caused by certain types of chemotherapy, which are known as emetogenic. Ricasetron is an ion-pair reconstituted drug that binds to the 5-HT4 receptor in the gastrointestinal tract. This prevents serotonin from binding to the receptor, preventing nausea and vomiting. Ricasetron has also been shown to decrease appetite, which may be due to its effects on neurokinin-1 (NK1). Ricasetron has been clinically proven for use in patients with cancer who are receiving chemotherapy.
Ricasetron is a type of fatty acid that is used as a chemical structure in various medications. It was first synthesized in 1972 by scientists at Sandoz Pharmaceuticals AG and was patented in 1974.
Propriedades químicas
Consulta técnica sobre: 3D-SEA08668 Ricasetron
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
